Clinical trial
Safety of Estrogens in Lupus: Hormone Replacement Therapy
NCT00000419 · NYU Langone Health, Other · Terminated
Key facts
| NCT number | NCT00000419 |
|---|---|
| Title | Safety of Estrogens in Lupus: Hormone Replacement Therapy |
| Official title | Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Hormone Replacement Therapy |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Office of Research on Women's Health (ORWH) |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | Premarin and Provera |
| Enrollment | 350 |
| Start date | Apr 1, 1996 |
| Completion | Aug 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | May 3, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: